Authors: Shusterman, S Grupp, SA Barr, R Carpentieri, D Zhao, HQ Maris, JM

Citation: S. Shusterman et al., The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease, CLIN CANC R, 7(4), 2001, pp. 977-984

Authors: Stern, JW Fang, JJ Shusterman, S Pierson, G Barr, R Pawel, B Diller, L Grupp, SA

Citation: Jw. Stern et al., Angiogenesis inhibitor TNP-470 during bone marrow transplant: Safety in a preclinical model, CLIN CANC R, 7(4), 2001, pp. 1026-1032

Authors: Grupp, SA Stern, JW Bunin, N Nancarrow, C Ross, AA Mogul, M Adams, R Grier, HE Gorlin, JB Shamberger, R Marcus, K Neuberg, D Weinstein, HJ Diller, L

Citation: Sa. Grupp et al., Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma, J CL ONCOL, 18(13), 2000, pp. 2567-2575

Authors: Shusterman, S Grupp, SA Maris, JM

Citation: S. Shusterman et al., Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470, MED PED ONC, 35(6), 2000, pp. 673-676

Authors: Donovan, J Temel, J Zuckerman, A Gribben, J Fang, JJ Pierson, G Ross, A Diller, L Grupp, SA

Citation: J. Donovan et al., CD34 selection as a stem cell purging strategy for neuroblastoma: Preclinical and clinical studies, MED PED ONC, 35(6), 2000, pp. 677-682

Authors: Grupp, SA Stern, JW Bunin, N Nancarrow, C Adams, R Gorlin, JB Griffin, G Diller, L

Citation: Sa. Grupp et al., Rapid-sequence tandem transplant for children with high-risk neuroblastoma, MED PED ONC, 35(6), 2000, pp. 696-700